Literature DB >> 3756062

The effect of cigarette smoking on 7-ethoxyresorufin O-deethylase and other monooxygenase activities in human liver: analyses with monoclonal antibodies.

O Pelkonen, M Pasanen, H Kuha, B Gachalyi, M Kairaluoma, E A Sotaniemi, S S Park, F K Friedman, H V Gelboin.   

Abstract

Four cytochrome P-450 enzyme activities, 7-ethoxyresorufin O-deethylase (ERDE), coumarin 7-hydroxylase (CH), 7-ethoxycoumarin O-deethylase (ECDE) and aryl hydrocarbon hydroxylase (AHH) were measured in human liver needle biopsy samples from smokers and non-smokers. Cigarette smoking was verified and quantitated by measuring plasma cotinine levels. Enzyme inhibitory monoclonal antibodies (MAb) to a 3-methylcholanthrene-induced (MAb 1-7-1) and phenobarbitone-induced (MAb 2-66-3) rat hepatic cytochrome P-450 were used to measure the contribution of MAb-defined, epitope-specific cytochromes P-450 to the total reaction measured for each of the above activities. ERDE activity was significantly elevated in the livers of cigarette smokers, whereas AHH, CH or ECDE activities were not affected by cigarette smoking. No correlation was observed between plasma cotinine concentration and ERDE activity. MAb 1-7-1 inhibited hepatic ERDE activity to a variable extent (from 0 to 65%), but had very little or no effect on AHH, CH or ECDE activities. The inhibitory effect of MAb 1-7-1 on ERDE activity was greater than 50% in the non-smokers. MAb 2-66-3 had no inhibitory effect on any of the enzyme activities studied. In contrast to liver both ERDE and AHH on human placental microsomes from cigarette smokers were inhibited by MAb 1-7-1. The MAb 2-66-3 was without effect. Cigarette smoking induces a form of P-450 in human liver, responsible for ERDE activity, that contains an epitope recognized by MAb 1-7-1. This form of cytochrome P-450 is insensitive to MAb 2-66-3 and is not contributing to AHH, CH or ECDE activities of human liver.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3756062      PMCID: PMC1401105          DOI: 10.1111/j.1365-2125.1986.tb05239.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  31 in total

1.  Monoclonal antibodies that inhibit enzyme activity of 3-methylcholanthrene-induced cytochrome P-450.

Authors:  S S Park; T Fujino; D West; F P Guengerich; H V Gelboin
Journal:  Cancer Res       Date:  1982-05       Impact factor: 12.701

Review 2.  Metabolism of polycyclic aromatic hydrocarbons: etiologic role in carcinogenesis.

Authors:  O Pelkonen; D W Nebert
Journal:  Pharmacol Rev       Date:  1982-06       Impact factor: 25.468

Review 3.  Cytochrome P-450 linked mixed function oxidase turnover of microsomal components and effects of inducers on the turnover phospholipids, proteins and specific enzymes.

Authors:  T Omura
Journal:  Pharmacol Ther       Date:  1980       Impact factor: 12.310

4.  Cigarette smoking and drug metabolism.

Authors:  K Vähäkangas; O Pelkonen; E Sotaniemi
Journal:  Clin Pharmacol Ther       Date:  1983-03       Impact factor: 6.875

Review 5.  Genetic mechanisms controlling the induction of polysubstrate monooxygenase (P-450) activities.

Authors:  D W Nebert; H J Eisen; M Negishi; M A Lang; L M Hjelmeland; A B Okey
Journal:  Annu Rev Pharmacol Toxicol       Date:  1981       Impact factor: 13.820

6.  Phenotyping of cytochromes P-450 in human tissues with monoclonal antibodies.

Authors:  T Fujino; S S Park; D West; H V Gelboin
Journal:  Proc Natl Acad Sci U S A       Date:  1982-06       Impact factor: 11.205

7.  Monoclonal antibody-directed radioimmunoassay of specific cytochromes P-450.

Authors:  B J Song; T Fujino; S S Park; F K Friedman; H V Gelboin
Journal:  J Biol Chem       Date:  1984-02-10       Impact factor: 5.157

8.  Cytochrome P-450 isozyme 1 from phenobarbital-induced rat liver: purification, characterization, and interactions with metyrapone and cytochrome b5.

Authors:  D J Waxman; C Walsh
Journal:  Biochemistry       Date:  1983-09-27       Impact factor: 3.162

9.  Correlations between cytochrome P-450 and oxidative metabolism of benzo[a]pyrene and 7-ethoxycoumarin in human liver in vitro and antipyrine elimination in vivo.

Authors:  O Pelkonen; E Sotaniemi; O Tokola; J T Ahokas
Journal:  Drug Metab Dispos       Date:  1980 Jul-Aug       Impact factor: 3.922

10.  Phenobarbital-induced rat liver cytochrome P-450. Purification and characterization of two closely related isozymic forms.

Authors:  D J Waxman; C Walsh
Journal:  J Biol Chem       Date:  1982-09-10       Impact factor: 5.157

View more
  16 in total

1.  Effects of smoking on benzo(alpha)pyrene- and glutathione-metabolizing enzymes in human lung tissue.

Authors:  C Bluhm
Journal:  Klin Wochenschr       Date:  1991-11-15

2.  The effect of cigarette smoking on drug metabolism in the liver and placenta: the use of cotinine in verifying smoking status.

Authors:  M Pasanen; K Vahakangas; E A Sotaniemi; O Pelkonen
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1988 Jan-Mar       Impact factor: 2.441

3.  A form of cytochrome P450 in man, orthologous to form d in the rat, catalyses the O-deethylation of phenacetin and is inducible by cigarette smoking.

Authors:  D Sesardic; A R Boobis; R J Edwards; D S Davies
Journal:  Br J Clin Pharmacol       Date:  1988-10       Impact factor: 4.335

Review 4.  Passively inhaled tobacco smoke: a challenge to toxicology and preventive medicine.

Authors:  H Remmer
Journal:  Arch Toxicol       Date:  1987-12       Impact factor: 5.153

Review 5.  Human hepatocytes as a key in vitro model to improve preclinical drug development.

Authors:  G Fabre; J Combalbert; Y Berger; J P Cano
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1990 Apr-Jun       Impact factor: 2.441

6.  Smoking and dietary intake of polycyclic aromatic hydrocarbons as sources of interindividual variability in the baseline excretion of 1-hydroxypyrene in urine.

Authors:  J G Van Rooij; M M Veeger; M M Bodelier-Bade; P T Scheepers; F J Jongeneelen
Journal:  Int Arch Occup Environ Health       Date:  1994       Impact factor: 3.015

7.  Effects of repeated intravenous administration of haem arginate upon hepatic metabolism of foreign compounds in rats and dogs.

Authors:  O Tokola
Journal:  Br J Pharmacol       Date:  1987-04       Impact factor: 8.739

8.  7-Alkoxyquinoline O-dealkylation by microsomes from human liver and placenta.

Authors:  J Hakkola; J Mäenpää; R T Mayer; S S Park; H V Gelboin; O Pelkonen
Journal:  Br J Clin Pharmacol       Date:  1992-11       Impact factor: 4.335

9.  On the bioactivation and genotoxic action of fluoranthene.

Authors:  C Vaca; M Törnqvist; U Rannug; K Lindahl-Kiessling; G Ahnström; L Ehrenberg
Journal:  Arch Toxicol       Date:  1992       Impact factor: 5.153

10.  Induction of cytochrome P4501A by smoking or omeprazole in comparison with UDP-glucuronosyltransferase in biopsies of human duodenal mucosa.

Authors:  J Buchthal; K E Grund; A Buchmann; D Schrenk; P Beaune; K W Bock
Journal:  Eur J Clin Pharmacol       Date:  1995       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.